COVID-19 vector-based vaccine causing thrombosis

J Biomol Struct Dyn. 2022;40(19):9568-9570. doi: 10.1080/07391102.2021.1927847. Epub 2021 May 17.


The number of people affected by COVID-19 is staggering and countries are rushing and competing to vaccinate their populations. However, there has been a concern about the association between COVID-19 vector-based vaccines and thrombosis. The proposed mechanism by which a COVID-19 vector-based vaccine can cause thrombosis is called vaccine-induced immune thrombotic thrombocytopenia (VITT). This commentary will provide an easy sketch of VITT as well as presentation of thrombosis after COVID-19 vaccines and proposed treatment.Communicated by Ramaswamy H. Sarma.

Keywords: COVID-19; thrombosis; vaccines.

Publication types

  • Review

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Vaccines*


  • COVID-19 Vaccines
  • Vaccines